- Home
- ERJ vs HALO Comparison
ERJ vs HALO Comparison
Compare ERJ & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERJ
- HALO
- Stock Information
- Founded
- ERJ 1969
- HALO 1998
- Country
- ERJ Brazil
- HALO United States
- Employees
- ERJ N/A
- HALO N/A
- Industry
- ERJ Aerospace
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ERJ Industrials
- HALO Health Care
- Exchange
- ERJ Nasdaq
- HALO Nasdaq
- Market Cap
- ERJ 10.5B
- HALO 7.6B
- IPO Year
- ERJ 2000
- HALO N/A
- Fundamental
- Price
- ERJ $56.71
- HALO $75.81
- Analyst Decision
- ERJ Buy
- HALO Buy
- Analyst Count
- ERJ 5
- HALO 8
- Target Price
- ERJ $58.25
- HALO $70.25
- AVG Volume (30 Days)
- ERJ 1.4M
- HALO 1.8M
- Earning Date
- ERJ 11-07-2025
- HALO 10-30-2025
- Dividend Yield
- ERJ 0.09%
- HALO N/A
- EPS Growth
- ERJ 11.89
- HALO 68.93
- EPS
- ERJ 0.53
- HALO 4.37
- Revenue
- ERJ $7,305,193,434.00
- HALO $1,178,672,000.00
- Revenue This Year
- ERJ N/A
- HALO $32.57
- Revenue Next Year
- ERJ $11.48
- HALO $23.25
- P/E Ratio
- ERJ $106.09
- HALO $17.40
- Revenue Growth
- ERJ 40.55
- HALO 34.97
- 52 Week Low
- ERJ $32.26
- HALO $42.01
- 52 Week High
- ERJ $62.09
- HALO $77.60
- Technical
- Relative Strength Index (RSI)
- ERJ 47.21
- HALO 70.39
- Support Level
- ERJ $56.76
- HALO $75.25
- Resistance Level
- ERJ $57.74
- HALO $77.60
- Average True Range (ATR)
- ERJ 1.48
- HALO 1.67
- MACD
- ERJ -0.33
- HALO -0.36
- Stochastic Oscillator
- ERJ 20.88
- HALO 70.66
About ERJ Embraer S.A.
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.